Delivery Order SPE2DB22D1106-SPE2DB25FEZS0
- Not listed
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply 100 tablets of 4mg dexamethasone for $1,446.24. Performance will occur at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania by November 29, 2023. As a prime contractor, Amerisourcebergen routinely provides pharmaceuticals and medical supplies to DLA Troop Support Medical in support of military treatment programs. No set-aside designation was...
- This is a $1,046.44 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,883,375 units of dexamethasone 4 mg tablets. The contract has an ultimate completion date of April 14, 2025 and was awarded on April 11, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between...
- This federal contract award, with a ceiling value of $2,113.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,190 units of dexamethasone 4 mg tablets, a medication used to treat various conditions. The contract is a Firm Fixed Price Delivery Order, with a performance period extending through May 9, 2025. The contract is not set aside for any...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $86.09 to Amerisourcebergen Drug Corp for the supply of 100 units of 4 mg dexamethasone tablets. As the prime contractor, Amerisourcebergen Drug Corp will deliver the pharmaceutical products from its facility located in Conshohocken, Pennsylvania under a one-day period of performance beginning on August 7, 2023. The order was placed utilizing Amerisourcebergen Corporation's Federal Supply Schedule contract vehicle...
- The Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $1,285.33 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 4,565,262,613 units of the pharmaceutical product Dexamethasone 4 mg Tablet, 100s. This contract has a firm fixed price and an ultimate completion date of July 29, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of dexamethasone 4 mg tablets. The contract is a Delivery Order, with a Firm Fixed Price pricing type, valued at $1,310.35. It does not have a set-aside designation, indicating a full and open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,587.19 delivery order is for the supply of Dexamethasone 10 mg/mL vials, a corticosteroid medication. The contract is a firm fixed-price arrangement with a completion date of September 16, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency Troop Support Medical awarded a $338,730 delivery order to Amerisourcebergen Drug Corporation for 4 mg dexamethasone tablets. Under the terms of the firm fixed price contract, Amerisourcebergen will deliver 100 count bottles of the generic corticosteroid tablets to a location in Conshohocken, Pennsylvania by June 26, 2023. No additional details were provided regarding the original solicitation or whether this delivery order was placed against an existing indefinite...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXAMETHASONE 4 MG TABLET UD 100S, a pharmaceutical product, with a ceiling value of $1,841.56 and a period of performance through June 18, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical worth $3,393.86 to supply 237ml of the pharmaceutical dexamethasone at 0.5mg/5ml. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with all supplies delivered by October 26, 2023. No set-aside designation was applied to this order, which was awarded against an existing indefinite-delivery contract held by...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEZS0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,671.80 to AmerisourceBergen Drug Corp for Dexamethasone 4 mg tablets in unit dose packages of 100 units. This firm fixed price, non-set-aside contract was awarded on July 25, 2025, with an ultimate completion date of July 28, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dexamethasone is a corticosteroid medication commonly used across military and federal healthcare systems for treating inflammation and various medical conditions. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. As a major pharmaceutical distributor, AmerisourceBergen supplies comprehensive medical commodities to support military healthcare operations globally, including specialty medications, vaccines, and medical devices. The company's federal contract portfolio demonstrates consistent capability to meet DLA procurement requirements through competitive awards, making it a critical vendor for Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 7/25/25 |